Aleroff
FDA Label NDC 81701-111

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Oksalud Colombia S A S for the product Aleroff (NDC 81701-111). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warnings, inactive ingredient, dosage & administration, troubleshooting, information for patients, otc - active ingredient, otc - purpose, indications & usage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.